Testing effectiveness (Phase 2)Study completedNCT01716806
What this trial is testing
Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)
Who this might be right for
Hodgkin DiseasePeripheral T Cell Lymphoma
Seagen Inc. 131